J Korean Neurosurg Soc.  2022 Nov;65(6):772-778. 10.3340/jkns.2022.0043.

Safety and Efficacy of Flow Diverter Therapy for Unruptured Intracranial Aneurysm Compared to Traditional Endovascular Strategy : A Multi-Center, Randomized, Open-Label Trial

• Kim J
• Hwang G
• Kim BT
• Park SQ
• Oh JS
• Ban SP
• Kwon OK
• Chung J
• Committee of Multicenter Research, Korean Neuroendovascular Society

• KMID: 2535837
• DOI: http://doi.org/10.3340/jkns.2022.0043

Abstract

Objective
: Endovascular treatment of large, wide-necked intracranial aneurysms by coil embolization is often complicated by low rates of complete occlusion and high rates of recurrence. A flow diverter device has been shown to be safe and effective for the treatment of not only large and giant unruptured aneurysms, but small and medium aneurysms. However, in Korea, its use has only recently been approved for aneurysms <10 mm. This study aims to compare the safety and efficacy of flow diversion and coil embolization for the treatment of unruptured aneurysms ≥7 mm.
Methods
: The participants will include patients aged between 19 and 75 years to be treated for unruptured cerebral aneurysms ≥7 mm for the first time or for recurrent aneurysms after initial endovascular coil embolization. Participants assigned to a flow diversion cohort will be treated using any of the following devices : Pipeline Flex Embolization Device with Shield Technology (Medtronic, Minneapolis, MN, USA), Surpass Evolve (Stryker Neurovascular, Fremont, CA, USA), and FRED or FRED Jr. (MicroVention, Tustin, CA, USA). Participants assigned to a coil embolization cohort will undergo traditional endovascular coiling. The primary endpoint will be complete occlusion confirmed by cerebral angiography at 12 months after treatment. Secondary safety outcomes will evaluate periprocedural and post-procedural complications for up to 12 months.
Results
: The trial will begin enrollment in 2022, and clinical data will be available after enrollment and follow-up.
Conclusion
: This article describes the aim and design of a multi-center, randomized, open-label trial to compare the safety and efficacy of flow diversion versus traditional endovascular treatment for unruptured cerebral aneurysms ≥7 mm.

Keyword

Aneurysm; Embolotherapy; Endovascular procedures; Prospective studies; Flow diverter

Reference

References

1. Becske T, Kallmes DF, Saatci I, McDougall CG, Szikora I, Lanzino G, et al. Pipeline for uncoilable or failed aneurysms: results from a multicenter clinical trial. Radiology. 267:858–868. 2013.

2. Briganti F, Leone G, Ugga L, Marseglia M, Solari D, Caranci F, et al. Safety and efficacy of flow re-direction endoluminal device (FRED) in the treatment of cerebral aneurysms: a single center experience. Acta Neurochir (Wien). 158:1745–1755. 2016.

3. Brinjikji W, Rabinstein AA, Nasr DM, Lanzino G, Kallmes DF, Cloft HJ. Better outcomes with treatment by coiling relative to clipping of unruptured intracranial aneurysms in the United States, 2001-2008. AJNR Am J Neuroradiol. 32:1071–1075. 2011.

4. Brisman JL, Song JK, Newell DW. Cerebral aneurysms. N Engl J Med. 355:928–939. 2006.

5. Brown RD Jr, Broderick JP. Unruptured intracranial aneurysms: epidemiology, natural history, management options, and familial screening. Lancet Neurol. 13:393–404. 2014.

6. Chalouhi N, Daou B, Barros G, Starke RM, Chitale A, Ghobrial G, et al. Matched comparison of flow diversion and coiling in small, noncomplex intracranial aneurysms. Neurosurgery. 81:92–97. 2017.

7. Chalouhi N, Jabbour P, Singhal S, Drueding R, Starke RM, Dalyai RT, et al. Stent-assisted coiling of intracranial aneurysms: predictors of complications, recanalization, and outcome in 508 cases. Stroke. 44:1348–1353. 2013.

8. Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, et al. Thrombolysis in myocardial infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation. 76:142–154. 1987.

9. Cognard C, Weill A, Spelle L, Piotin M, Castaings L, Rey A, et al. Longterm angiographic follow-up of 169 intracranial berry aneurysms occluded with detachable coils. Radiology. 212:348–356. 1999.

10. Ferns SP, Sprengers ME, van Rooij WJ, Rinkel GJ, van Rijn JC, Bipat S, et al. Coiling of intracranial aneurysms: a systematic review on initial occlusion and reopening and retreatment rates. Stroke. 40:e523–e529. 2009.

11. Ferns SP, Sprengers ME, van Rooij WJ, van Zwam WH, de Kort GA, Velthuis BK, et al. Late reopening of adequately coiled intracranial aneurysms: frequency and risk factors in 400 patients with 440 aneurysms. Stroke. 42:1331–1337. 2011.

12. Gory B, Turjman F. Endovascular treatment of 404 intracranial aneurysms treated with nexus detachable coils: short-term and mid-term results from a prospective, consecutive, European multicenter study. Acta Neurochir (Wien). 156:831–837. 2014.

13. Hanel RA, Kallmes DF, Lopes DK, Nelson PK, Siddiqui A, Jabbour P, et al. Prospective study on embolization of intracranial aneurysms with the pipeline device: the PREMIER study 1 year results. J Neurointerv Surg. 12:62–66. 2020.

14. Ishii A, Chihara H, Kikuchi T, Arai D, Ikeda H, Miyamoto S. Contribution of the straightening effect of the parent artery to decreased recanalization in stent-assisted coiling of large aneurysms. J Neurosurg. 127:1063–1069. 2017.

15. Lee JY, Seo JH, Cho YD, Kang HS, Han MH. Endovascular treatment of wide-neck intracranial aneurysms using a microcatheter protective technique: results and outcomes in 75 aneurysms. AJNR Am J Neuroradiol. 32:917–922. 2011.

16. Meyers PM, Schumacher HC, Higashida RT, Derdeyn CP, Nesbit GM, Sacks D, et al. Reporting standards for endovascular repair of saccular intracranial cerebral aneurysms. J Vasc Interv Radiol. 20(7 Suppl):S435–S450. 2009.

17. Molyneux A, Kerr R; International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group, Stratton I, Sandercock P, Clarke M, et al. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomized trial. J Stroke Cerebrovasc Dis. 11:304–314. 2002.

18. Molyneux AJ, Kerr RS, Birks J, Ramzi N, Yarnold J, Sneade M, et al. Risk of recurrent subarachnoid haemorrhage, death, or dependence and standardised mortality ratios after clipping or coiling of an intracranial aneurysm in the International Subarachnoid Aneurysm Trial (ISAT): longterm follow-up. Lancet Neurol. 8:427–433. 2009.

19. Ogilvy CS, Chua MH, Fusco MR, Griessenauer CJ, Harrigan MR, Sonig A, et al. Validation of a system to predict recanalization after endovascular treatment of intracranial aneurysms. Neurosurgery. 77:168–174. discussion 173-174. 2015.

20. Park KY, Yeon JY, Kim BM, Jeon P, Kim JH, Jang CK, et al. Efficacy and safety of flow-diverter therapy for recurrent aneurysms after stentassisted coiling. AJNR Am J Neuroradiol. 41:663–668. 2020.

21. Pierot L, Spelle L, Berge J, Januel AC, Herbreteau D, Aggour M, et al. SAFE study (safety and efficacy analysis of FRED embolic device in aneurysm treatment): 1-year clinical and anatomical results. J Neurointerv Surg. 11:184–189. 2019.

22. Pumar JM, Mosqueira A, Cuellar H, Dieguez B, Guimaraens L, Masso J, et al. Expanding the use of flow diverters beyond their initial indication: treatment of small unruptured aneurysms. J Neurointerv Surg. 10:245–248. 2018.

23. Ravindran K, Casabella AM, Cebral J, Brinjikji W, Kallmes DF, Kadirvel R. Mechanism of action and biology of flow diverters in the treatment of intracranial aneurysms. Neurosurgery. 86(Suppl 1):S13–S19. 2020.

24. Rinkel GJ. Intracranial aneurysm screening: indications and advice for practice. Lancet Neurol. 4:122–128. 2005.

25. Rinkel GJ, Djibuti M, Algra A, van Gijn J. Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke. 29:251–256. 1998.

26. Shimizu K, Imamura H, Mineharu Y, Adachi H, Sakai C, Sakai N. Endovascular treatment of unruptured paraclinoid aneurysms: single-center experience with 400 cases and literature review. AJNR Am J Neuroradiol. 37:679–685. 2016.

27. Shin DS, Carroll CP, Elghareeb M, Hoh BL, Kim BT. The evolution of flow-diverting stents for cerebral aneurysms; historical review, modern application, complications, and future direction. J Korean Neurosurg Soc. 63:137–152. 2020.

28. UCAS Japan Investigators, Morita A, Kirino T, Hashi K, Aoki N, Fukuhara S, et al. The natural course of unruptured cerebral aneurysms in a Japanese cohort. N Engl J Med. 366:2474–2482. 2012.

29. Van Gijn J, Kerr RS, Rinkel GJ. Subarachnoid haemorrhage. Lancet. 369:306–318. 2007.

30. Xia JL, Li GL, Liu HE, Feng-Fei X, Gu XD. Flow-diverting device versus coil embolization for unruptured intracranial aneurysm: a meta-analysis. Medicine (Baltimore). 100:e26351. 2021.

31. Yao X, Ma J, Li H, Shen H, Lu X, Chen G. Safety and efficiency of flow diverters for treating small intracranial aneurysms: a systematic review and meta-analysis. J Int Med Res. 45:11–21. 2017.

32. Zhou G, Zhu YQ, Su M, Gao KD, Li MH. Flow-diverting devices versus coil embolization for intracranial aneurysms: a systematic literature review and meta-analysis. World Neurosurgery. 88:640–645. 2016.